메뉴 건너뛰기




Volumn 11, Issue 4, 2006, Pages 366-372

The role of veto cells in bone marrow transplantation

Author keywords

CD8; FasL; Nonmyeloablative; Tolerance; Transforming growth factor ; Veto

Indexed keywords

CD34 ANTIGEN; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS ANTIGEN;

EID: 33746352041     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000236698.45210.3e     Document Type: Review
Times cited : (8)

References (49)
  • 1
    • 24644480633 scopus 로고    scopus 로고
    • Graft-vs-host disease after nonmyeloablative hematopoietic cell transplantation
    • Mielcarek M, Storb R. Graft-vs-host disease after nonmyeloablative hematopoietic cell transplantation. Leuk Lymphoma 2005; 46:1251-1260. An update of clinical outcome in nonmyeloablative transplants.
    • (2005) Leuk Lymphoma , vol.46 , pp. 1251-1260
    • Mielcarek, M.1    Storb, R.2
  • 2
    • 0024333302 scopus 로고
    • Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts
    • Lapidot T, Terenzi A, Singer TS, et al. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood 1989; 73:2025-2032.
    • (1989) Blood , vol.73 , pp. 2025-2032
    • Lapidot, T.1    Terenzi, A.2    Singer, T.S.3
  • 3
    • 0026539577 scopus 로고
    • Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation
    • Uharek L, Gassmann W, Glass B, et al. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood 1992; 79:1612-1621.
    • (1992) Blood , vol.79 , pp. 1612-1621
    • Uharek, L.1    Gassmann, W.2    Glass, B.3
  • 4
    • 0032558759 scopus 로고    scopus 로고
    • Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
    • Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339:1186-1193.
    • (1998) N Engl J Med , vol.339 , pp. 1186-1193
    • Aversa, F.1    Tabilio, A.2    Velardi, A.3
  • 5
    • 0033178256 scopus 로고    scopus 로고
    • Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients
    • Reisner Y, Martelli MF. Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients. Immunol Today 1999; 20:343-347.
    • (1999) Immunol Today , vol.20 , pp. 343-347
    • Reisner, Y.1    Martelli, M.F.2
  • 7
    • 20644470338 scopus 로고    scopus 로고
    • Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
    • Aversa F, Terenzi A, Tabilio A, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005; 23:3447-3454.
    • (2005) J Clin Oncol , vol.23 , pp. 3447-3454
    • Aversa, F.1    Terenzi, A.2    Tabilio, A.3
  • 8
    • 0032571946 scopus 로고    scopus 로고
    • Tolerance induction by 'megadose' hematopoietic transplants: Donor-type human CD34 stem cells induce potent specific reduction of host antidonor cytotoxic T lymphocyte precursors in mixed lymphocyte culture
    • Rachamim N, Gan J, Segall H, et al. Tolerance induction by 'megadose' hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host antidonor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 1998; 65:1386-1393.
    • (1998) Transplantation , vol.65 , pp. 1386-1393
    • Rachamim, N.1    Gan, J.2    Segall, H.3
  • 10
    • 20144373526 scopus 로고    scopus 로고
    • Immune regulatory activity of CD34+ progenitor cells: Evidence for a deletion-based mechanism mediated by TNF-α
    • Gur H, Krauthgamer R, Bachar-Lustig E, et al. Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-α. Blood 2005; 105:2585-2593. Demonstration of the role of death molecules other than FasL in the veto activity of CD34 stem cells.
    • (2005) Blood , vol.105 , pp. 2585-2593
    • Gur, H.1    Krauthgamer, R.2    Bachar-Lustig, E.3
  • 11
    • 0019205672 scopus 로고
    • An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it
    • Miller RG. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature 1980; 287:544-546.
    • (1980) Nature , vol.287 , pp. 544-546
    • Miller, R.G.1
  • 12
    • 0020564323 scopus 로고
    • Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens
    • Muraoka S, Miller RG. Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Immunol 1983; 131:45-49.
    • (1983) J Immunol , vol.131 , pp. 45-49
    • Muraoka, S.1    Miller, R.G.2
  • 13
    • 0021717453 scopus 로고
    • Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong antiself suppressive activity
    • Claesson MH, Miller RG. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong antiself suppressive activity. J Exp Med 1984; 160:1702-1716.
    • (1984) J Exp Med , vol.160 , pp. 1702-1716
    • Claesson, M.H.1    Miller, R.G.2
  • 14
    • 0021132017 scopus 로고
    • Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes
    • Fink PJ, Rammensee HG, Benedetto JD, et al. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes. J Immunol 1984; 133:1769-1774.
    • (1984) J Immunol , vol.133 , pp. 1769-1774
    • Fink, P.J.1    Rammensee, H.G.2    Benedetto, J.D.3
  • 15
    • 0021135798 scopus 로고
    • Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them
    • Fink PJ, Rammensee HG, Bevan MJ. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them. J Immunol 1984; 133:1775-1781.
    • (1984) J Immunol , vol.133 , pp. 1775-1781
    • Fink, P.J.1    Rammensee, H.G.2    Bevan, M.J.3
  • 16
    • 0026777361 scopus 로고
    • Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen
    • Zhang LI, Martin DR, Fung-Leung WP, et al. Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen. J Immunol 1992; 148:3740-3745.
    • (1992) J Immunol , vol.148 , pp. 3740-3745
    • Zhang, L.I.1    Martin, D.R.2    Fung-Leung, W.P.3
  • 17
    • 0028123516 scopus 로고
    • Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism
    • Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57:101-115.
    • (1994) Transplantation , vol.57 , pp. 101-115
    • Thomas, J.M.1    Carver, F.M.2    Kasten-Jolly, J.3
  • 18
    • 0028295821 scopus 로고
    • A role for transforming growth factor-beta in the veto mechanism in transplant tolerance
    • Verbanac KM, Carver FM, Haisch CE, Thomas JM. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. Transplantation 1994; 57:893-900.
    • (1994) Transplantation , vol.57 , pp. 893-900
    • Verbanac, K.M.1    Carver, F.M.2    Haisch, C.E.3    Thomas, J.M.4
  • 19
    • 0033228366 scopus 로고    scopus 로고
    • Donor bone marrow and transplantation tolerance: Historical perspectives, molecular mechanisms and future directions
    • George JF, Goldstein DR, Thomas JM. Donor bone marrow and transplantation tolerance: historical perspectives, molecular mechanisms and future directions [review]. Int J Mol Med 1999; 4:475-482.
    • (1999) Int J Mol Med , vol.4 , pp. 475-482
    • George, J.F.1    Goldstein, D.R.2    Thomas, J.M.3
  • 20
    • 0033680730 scopus 로고    scopus 로고
    • Antithird party CD8+ CTLs as potent veto cells: Coexpression of CD8 and FasL is a prerequisite
    • Reich-Zeliger S, Zhao Y, Krauthgamer R, et al. Antithird party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. Immunity 2000; 13:507-515.
    • (2000) Immunity , vol.13 , pp. 507-515
    • Reich-Zeliger, S.1    Zhao, Y.2    Krauthgamer, R.3
  • 21
    • 0032899594 scopus 로고    scopus 로고
    • + antiviral T cells by viral antigen-positive veto cells
    • + antiviral T cells by viral antigen-positive veto cells. J Virol 1999; 73:3826-3834.
    • (1999) J Virol , vol.73 , pp. 3826-3834
    • Rich, R.F.1    Green, W.R.2
  • 22
    • 0025883099 scopus 로고
    • Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC
    • Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science 1991; 252:1424-1427.
    • (1991) Science , vol.252 , pp. 1424-1427
    • Sambhara, S.R.1    Miller, R.G.2
  • 23
    • 0033556785 scopus 로고    scopus 로고
    • Immunoregulatory role of CD8a in the veto effect: Transforming growth factor-β1 activation
    • Asiedu C, Meng Y, Wang W, et al. Immunoregulatory role of CD8a in the veto effect: transforming growth factor-β1 activation. Transplantation 1999; 67:372-380.
    • (1999) Transplantation , vol.67 , pp. 372-380
    • Asiedu, C.1    Meng, Y.2    Wang, W.3
  • 24
    • 0029980866 scopus 로고    scopus 로고
    • Hybrid antibody mediated veto of cytotoxic T lymphocyte responses
    • Qi Y, Berg R, Singleton MA, et al. Hybrid antibody mediated veto of cytotoxic T lymphocyte responses. J Exp Med 1996; 183:1973-1980.
    • (1996) J Exp Med , vol.183 , pp. 1973-1980
    • Qi, Y.1    Berg, R.2    Singleton, M.A.3
  • 25
    • 0032834109 scopus 로고    scopus 로고
    • The molecular mechanisms of veto mediated regulation of alloresponsiveness
    • George J, Thomas J. The molecular mechanisms of veto mediated regulation of alloresponsiveness. J Mol Med 1999; 77:519-526.
    • (1999) J Mol Med , vol.77 , pp. 519-526
    • George, J.1    Thomas, J.2
  • 26
    • 0027382190 scopus 로고
    • Generation of lymphokine-activated killer cells with veto and natural suppressor activity from patients with leukemias and lymphomas
    • Cheruku R, Uberti J, Martilotti F, Kaplan J. Generation of lymphokine-activated killer cells with veto and natural suppressor activity from patients with leukemias and lymphomas. Transplantation 1993; 56:1037-1040.
    • (1993) Transplantation , vol.56 , pp. 1037-1040
    • Cheruku, R.1    Uberti, J.2    Martilotti, F.3    Kaplan, J.4
  • 27
    • 0026547417 scopus 로고
    • Human lymphokine activated killer (LAK) cells suppress generation of allospecific cytotoxic T cells: Implications for use of LAK cells to prevent graft-versus-host disease in allogeneic bone marrow transplantation
    • Uberti J, Martilotti F, Chou TH, Kaplan J. Human lymphokine activated killer (LAK) cells suppress generation of allospecific cytotoxic T cells: implications for use of LAK cells to prevent graft-versus-host disease in allogeneic bone marrow transplantation. Blood 1992; 79:261-268.
    • (1992) Blood , vol.79 , pp. 261-268
    • Uberti, J.1    Martilotti, F.2    Chou, T.H.3    Kaplan, J.4
  • 28
    • 9144266371 scopus 로고    scopus 로고
    • Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells
    • Reich-Zeliger S, Bachar-Lustig E, Gan J, Reisner Y. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells. J Immunol 2004; 173:6654-6659.
    • (2004) J Immunol , vol.173 , pp. 6654-6659
    • Reich-Zeliger, S.1    Bachar-Lustig, E.2    Gan, J.3    Reisner, Y.4
  • 29
    • 0031938903 scopus 로고    scopus 로고
    • An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow
    • George JF, Sweeney SD, Kirklin JK, et al. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nat Med 1998; 4:333-335.
    • (1998) Nat Med , vol.4 , pp. 333-335
    • George, J.F.1    Sweeney, S.D.2    Kirklin, J.K.3
  • 30
    • 9144242988 scopus 로고    scopus 로고
    • Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis
    • Reich-Zeliger S, Gan J, Bachar-Lustig E, Reisner Y. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis. J Immunol 2004; 173:6660-6666.
    • (2004) J Immunol , vol.173 , pp. 6660-6666
    • Reich-Zeliger, S.1    Gan, J.2    Bachar-Lustig, E.3    Reisner, Y.4
  • 31
    • 33644825001 scopus 로고    scopus 로고
    • Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of antiretroviral CTL
    • Rich RF, Cook WJ, Green WR. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of antiretroviral CTL. Virology 2006; 346:287-300. An interesting demonstration of the role of Fas/FasL in veto CTLs presenting viral antigen and thereby deleting antiviral effector cells.
    • (2006) Virology , vol.346 , pp. 287-300
    • Rich, R.F.1    Cook, W.J.2    Green, W.R.3
  • 32
    • 0033026567 scopus 로고    scopus 로고
    • T cytotoxic lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape
    • Green WR. T cytotoxic lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape. Immunol Rev 1999; 168:271-286.
    • (1999) Immunol Rev , vol.168 , pp. 271-286
    • Green, W.R.1
  • 33
    • 0026672304 scopus 로고
    • Cyclosporine A and peripheral tolerance: Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes
    • Hiruma K, Gress RE. Cyclosporine A and peripheral tolerance: inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes. J Immunol 1992; 149:1539-1547.
    • (1992) J Immunol , vol.149 , pp. 1539-1547
    • Hiruma, K.1    Gress, R.E.2
  • 34
    • 33746324887 scopus 로고    scopus 로고
    • The role of ERK5 signaling in tolerance induction by veto CTLs
    • Reich-Zeliger S, Hanoch T, Seger R, Reisner Y. The role of ERK5 signaling in tolerance induction by veto CTLs [abstract]. Blood 2005; 106:3302.
    • (2005) Blood , vol.106 , pp. 3302
    • Reich-Zeliger, S.1    Hanoch, T.2    Seger, R.3    Reisner, Y.4
  • 35
    • 0035003410 scopus 로고    scopus 로고
    • Veto activity of activated bone marrow does not require perforin and Fas ligand
    • Chrobak P, Gress RE. Veto activity of activated bone marrow does not require perforin and Fas ligand. Cell Immunol 2001; 208:80-87.
    • (2001) Cell Immunol , vol.208 , pp. 80-87
    • Chrobak, P.1    Gress, R.E.2
  • 36
    • 0141567711 scopus 로고    scopus 로고
    • Antithird-party veto CTLs overcome rejection of hematopoietic allografts: Synergism with rapamycin and BM cell dose
    • Bachar-Lustig E, Reich-Zeliger S, Reisner Y. Antithird-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood 2003; 102:1943-1950.
    • (2003) Blood , vol.102 , pp. 1943-1950
    • Bachar-Lustig, E.1    Reich-Zeliger, S.2    Reisner, Y.3
  • 37
    • 0035993843 scopus 로고    scopus 로고
    • Use of calcineurin inhibitors in pediatric liver transplantation: A single-center experience
    • Taylor RM, Cheeseman P, Rela M, et al. Use of calcineurin inhibitors in pediatric liver transplantation: a single-center experience. Transplant Proc 2002; 34:1974-1975.
    • (2002) Transplant Proc , vol.34 , pp. 1974-1975
    • Taylor, R.M.1    Cheeseman, P.2    Rela, M.3
  • 38
    • 33646703806 scopus 로고    scopus 로고
    • Overcoming T cell mediated rejection of bone marrow allografts by Treg cells: Synergism with veto cells and Rapamycin
    • In press
    • Steiner D, Brunicki N, Bachar-Lustig E. Overcoming T cell mediated rejection of bone marrow allografts by Treg cells: synergism with veto cells and Rapamycin. Exp Hematol 2006; In press.
    • (2006) Exp Hematol
    • Steiner, D.1    Brunicki, N.2    Bachar-Lustig, E.3
  • 39
    • 30344450069 scopus 로고    scopus 로고
    • Tolerance induction by third-party 'off-the-shelf' CD4+CD25+ Treg cells
    • Steiner D, Brunicki N, Blazar BR, et al. Tolerance induction by third-party 'off-the-shelf' CD4+CD25+ Treg cells. Exp Hematol 2006; 34:66-71.
    • (2006) Exp Hematol , vol.34 , pp. 66-71
    • Steiner, D.1    Brunicki, N.2    Blazar, B.R.3
  • 40
    • 31044446127 scopus 로고    scopus 로고
    • Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cells
    • Anderson KM, Zimring JC. Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cells. Transplantation 2006; 81:88-94. Interesting proposal that rapamycin enhances veto activity by increasing the susceptibility of the effector cells after activation by the relevant stimulator cells.
    • (2006) Transplantation , vol.81 , pp. 88-94
    • Anderson, K.M.1    Zimring, J.C.2
  • 41
    • 33746328431 scopus 로고    scopus 로고
    • Effective deletion of anti-donor host memory effector cells by anti3rd party veto CTLs: Implications to tolerance induction in presensitized bone marrow recipients
    • Reich-Zeliger S, Bachar-Lustig E, Reisner Y. Effective deletion of anti-donor host memory effector cells by anti3rd party veto CTLs: implications to tolerance induction in presensitized bone marrow recipients [abstract]. Blood 2004; 104:44.
    • (2004) Blood , vol.104 , pp. 44
    • Reich-Zeliger, S.1    Bachar-Lustig, E.2    Reisner, Y.3
  • 42
    • 21544444739 scopus 로고    scopus 로고
    • Large-scale preparation of human antithird-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: A new source for graft facilitating cells in bone marrow transplantation
    • Aviner S, Yao X, Krauthgamer R, et al. Large-scale preparation of human antithird-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. Hum Immunol 2005; 66:644-652. Description of the methodology for generation of human veto CTLs depleted of GVH reactivity.
    • (2005) Hum Immunol , vol.66 , pp. 644-652
    • Aviner, S.1    Yao, X.2    Krauthgamer, R.3
  • 43
    • 0034067656 scopus 로고    scopus 로고
    • Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: Considerations for the allogeneic transplantation therapy of leukemia and lymphoma
    • Fowler DH, Gress RE. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Leuk Lymphoma 2000; 38:221-234.
    • (2000) Leuk Lymphoma , vol.38 , pp. 221-234
    • Fowler, D.H.1    Gress, R.E.2
  • 44
    • 0142214622 scopus 로고    scopus 로고
    • CD3/CD28-costimulated T1 and T2 subsets: Differential in vivo allosensitization generates distinct GVT and GVHD effects
    • Jung U, Foley JE, Erdmann AA, et al. CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects. Blood 2004; 102:3439-3446.
    • (2004) Blood , vol.102 , pp. 3439-3446
    • Jung, U.1    Foley, J.E.2    Erdmann, A.A.3
  • 45
    • 4344624106 scopus 로고    scopus 로고
    • Co-stimulated/Tc2 cells abrogate murine marrow graft rejection
    • Erdmann AA, Jung U, Foley JE, et al. Co-stimulated/Tc2 cells abrogate murine marrow graft rejection. Biol Blood Marrow Transplant 2004; 10:604-613.
    • (2004) Biol Blood Marrow Transplant , vol.10 , pp. 604-613
    • Erdmann, A.A.1    Jung, U.2    Foley, J.E.3
  • 46
    • 18744415962 scopus 로고    scopus 로고
    • Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant
    • Fowler D, Hou J, Foley J, et al. Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant. Cytotherapy 2002; 4:429-430.
    • (2002) Cytotherapy , vol.4 , pp. 429-430
    • Fowler, D.1    Hou, J.2    Foley, J.3
  • 47
    • 1142310696 scopus 로고    scopus 로고
    • Immunoablative reduced-intensity stem cell transplantation: Potential role of donor Th2 and Tc2 cells
    • Fowler DH, Bishop MR, Gress RE. Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells. Semin Oncol 2004; 31:56-67.
    • (2004) Semin Oncol , vol.31 , pp. 56-67
    • Fowler, D.H.1    Bishop, M.R.2    Gress, R.E.3
  • 48
    • 0037418284 scopus 로고    scopus 로고
    • Hematopoiesis-restricted minor histocompatibility antigens HA-1- Or HA-2-specific T cells can induce complete remissions of relapsed leukaemia
    • U S A
    • Marijt WA, Heemskerk MH, Kloosterboer FM, et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukaemia. Proc Natl Acad Sci U S A 2003; 100:2742-2747.
    • (2003) Proc Natl Acad Sci , vol.100 , pp. 2742-2747
    • Marijt, W.A.1    Heemskerk, M.H.2    Kloosterboer, F.M.3
  • 49
    • 0033826798 scopus 로고    scopus 로고
    • Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells
    • Nair SK, Heiser A, Boczkowski D, et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med 2000; 6:1011-1017.
    • (2000) Nat Med , vol.6 , pp. 1011-1017
    • Nair, S.K.1    Heiser, A.2    Boczkowski, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.